Tara Lech/thrombosis.org
Feb 21, 2026, 12:41
Tara Lech: New Guidelines for Comprehensive, Evidence Based Management of PE
Tara Lech, Director of Anticoagulation Services at Beth Israel Lahey Health and Member Board of Directors at Anticoagulation Forum, shared a post LinkedIn:
“New guidelines for comprehensive, evidence based management of PE
Collaborated on and endorsed by 8 societies
What you will find:
- Acute PE Clinical Categories (A-E)
- Clearly defined risk factors to screen for during a targeted history and physical examination
- Overview of an effective PERT Team
- LMWH preferred over unfractionated Heparin for most patients
- Considerations for special populations (Obesity, Thrombotic APS, Brain Tumors, CKD, Pregnancy, Breastfeeding, Chronic Liver Disease)
- Recommendations for timing and utility of LMWH levels, noting Class III
Recommendation: No Benefit for most patients with acute PE ”
Stay updated with Hemostasis Today.
-
May 23, 2026, 16:55Rahul Bhargava: Ensure Equal Recognition of Clinical Haematologists in Blood Cancer Clinical Trials
-
May 23, 2026, 16:44Brian O Mahony: World Haemophilia Day Receives Global WHO Recognition
-
May 23, 2026, 16:44Yusuf Hameed: Gene Therapy Could Reduce Lifetime Treatment Burden in Hemophilia A
-
May 23, 2026, 16:43Chokri Ben Lamine: Pacritinib Is a Key JAK Inhibitor for Cytopenic Myelofibrosis
-
May 23, 2026, 16:42Bartosz Hudzik: Bleeding Risk Alone Should Not Determine Treatment Intensity
-
May 23, 2026, 16:42Shimels Tessema: Celebrating the WHA Resolution on Hemophilia and Other Bleeding Disorders
-
May 23, 2026, 16:38José Octavio Alva Bucio: Securing the Future of Plasma and Blood-Derived Medicines
-
May 23, 2026, 16:33Why Are We Dismantling What Powers Humanity and the Global Economy? – ASH
-
May 23, 2026, 16:24Marc Wittwer: A Practical Viscoelastic-Guided Algorithm for Trauma-Induced Coagulopathy in Clinical Workflow